(Reuters) -The U.S. Food and Drug Administration has lifted its clinical hold on ... combination shot and flu vaccine to ...
Novavax (NASDAQ:NVAX) shares climbed 12% premarket on Monday after the U.S. FDA lifted clinical hold on the investigational new drug application for the pharma firm’s COVID-19-Influenza ...
Novavax can move forward with a trial for its combined Covid-19 and influenza vaccine after regulators lifted a clinical hold ... plans to file for FDA approval of its own combo vaccine by ...
The lifted hold applies to Novavax’s flu ... combo vaccine. A trial participant who’d received the shot in Jan. 2023 later developed motor neuropathy, or muscle weakness, leading the FDA ...
The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines after a safety concern was found to be unrelated ...
(Reuters) -The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID ... flu vaccines after a safety concern was found unrelated to the ...